Literature DB >> 23314847

Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice.

P Luo1, A Dematteo, Z Wang, L Zhu, A Wang, H-S Kim, A Pozzi, J M Stafford, J M Luther.   

Abstract

AIMS/HYPOTHESIS: Obesity is associated with aldosterone excess, hypertension and the metabolic syndrome, but the relative contribution of aldosterone to obesity-related complications is debated. We previously demonstrated that aldosterone impairs insulin secretion, and that genetic aldosterone deficiency increases glucose-stimulated insulin secretion in vivo. We hypothesised that elimination of endogenous aldosterone would prevent obesity-induced insulin resistance and hyperglycaemia.
METHODS: Wild-type and aldosterone synthase-deficient (As (-/-)) mice were fed a high-fat (HF) or normal chow diet for 12 weeks. We assessed insulin sensitivity and insulin secretion using clamp methodology and circulating plasma adipokines, and examined adipose tissue via histology.
RESULTS: HF diet induced weight gain similarly in the two groups, but As (-/-) mice were protected from blood glucose elevation. HF diet impaired insulin sensitivity similarly in As (-/-) and wild-type mice, assessed by hyperinsulinaemic-euglycaemic clamps. Fasting and glucose-stimulated insulin were higher in HF-fed As (-/-) mice than in wild-type controls. Although there was no difference in insulin sensitivity during HF feeding in As (-/-) mice compared with wild-type controls, fat mass, adipocyte size and adiponectin increased, while adipose macrophage infiltration decreased. HF feeding significantly increased hepatic steatosis and triacylglycerol content in wild-type mice, which was attenuated in aldosterone-deficient mice. CONCLUSIONS/
INTERPRETATION: These studies demonstrate that obesity induces insulin resistance independently of aldosterone and adipose tissue inflammation, and suggest a novel role for aldosterone in promoting obesity-induced beta cell dysfunction, hepatic steatosis and adipose tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314847      PMCID: PMC3593801          DOI: 10.1007/s00125-012-2814-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  50 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Hypertension, the potassium ion and impaired carbohydrate tolerance.

Authors:  J W Conn
Journal:  N Engl J Med       Date:  1965-11-18       Impact factor: 91.245

3.  Genetic variation in aldosterone synthase predicts plasma glucose levels.

Authors:  K Ranade; K D Wu; N Risch; M Olivier; D Pei; C F Hsiao; L M Chuang; L T Ho; E Jorgenson; R Pesich; Y D Chen; V Dzau; A Lin; R A Olshen; D Curb; D R Cox; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

4.  Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes.

Authors:  G S Meneilly; C H McIntosh; R A Pederson; J F Habener; R Gingerich; J M Egan; D T Finegood; D Elahi
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

5.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Serum aldosterone and the incidence of hypertension in nonhypertensive persons.

Authors:  Ramachandran S Vasan; Jane C Evans; Martin G Larson; Peter W F Wilson; James B Meigs; Nader Rifai; Emelia J Benjamin; Daniel Levy
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

7.  Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion.

Authors:  Theodore L Goodfriend; Dennis L Ball; Brent M Egan; William B Campbell; Kasem Nithipatikom
Journal:  Hypertension       Date:  2004-01-12       Impact factor: 10.190

8.  Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

Authors:  Christine C Jensen; Miriam Cnop; Rebecca L Hull; Wilfred Y Fujimoto; Steven E Kahn
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

Authors:  M L Tuck; J Sowers; L Dornfeld; G Kledzik; M Maxwell
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

10.  Human adipocytes secrete mineralocorticoid-releasing factors.

Authors:  M Ehrhart-Bornstein; V Lamounier-Zepter; A Schraven; J Langenbach; H S Willenberg; A Barthel; H Hauner; S M McCann; W A Scherbaum; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

View more
  14 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Authors:  Margarita Pizarro; Nancy Solís; Pablo Quintero; Francisco Barrera; Daniel Cabrera; Pamela Rojas-de Santiago; Juan P Arab; Oslando Padilla; Juan C Roa; Han Moshage; Alexander Wree; Eugenia Inzaugarat; Ariel E Feldstein; Carlos E Fardella; Rene Baudrand; Arnoldo Riquelme; Marco Arrese
Journal:  Liver Int       Date:  2015-02-23       Impact factor: 5.828

3.  Dietary sodium restriction decreases insulin secretion without affecting insulin sensitivity in humans.

Authors:  James M Luther; Loretta M Byrne; Chang Yu; Thomas J Wang; Nancy J Brown
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

Review 4.  Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.

Authors:  Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

5.  Muscle transcriptome response to ACTH administration in a free-ranging marine mammal.

Authors:  Jane I Khudyakov; Cory D Champagne; Likit Preeyanon; Rudy M Ortiz; Daniel E Crocker
Journal:  Physiol Genomics       Date:  2015-06-02       Impact factor: 3.107

Review 6.  Aldosterone in vascular and metabolic dysfunction.

Authors:  James M Luther
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

Review 7.  Effects of aldosterone on insulin sensitivity and secretion.

Authors:  James M Luther
Journal:  Steroids       Date:  2014-09-04       Impact factor: 2.668

8.  Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury.

Authors:  Wai Yan Sun; Bo Bai; Cuiting Luo; Kangmin Yang; Dahui Li; Donghai Wu; Michel Félétou; Nicole Villeneuve; Yang Zhou; Junwei Yang; Aimin Xu; Paul M Vanhoutte; Yu Wang
Journal:  JCI Insight       Date:  2018-09-06

9.  Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.

Authors:  Gail K Adler; Gillian R Murray; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Robert Manning; Dungeng Peng; James M Luther
Journal:  Hypertension       Date:  2020-03-16       Impact factor: 10.190

10.  Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation.

Authors:  Suman Srinivasa; Kathleen V Fitch; Nabiha Quadri; Patrick Maehler; Timothy K O'Malley; Edgar L Martinez-Salazar; Tricia H Burdo; Meghan Feldpausch; Martin Torriani; Gail K Adler; Steven K Grinspoon
Journal:  J Endocr Soc       Date:  2018-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.